Anika Therapeutics Inc. (ANIK) financial statements (2022 and earlier)

Company profile

Business Address 32 WIGGINS AVENUE
BEDFORD, MA 01730
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments94,38698,318184,943159,014157,256124,761
Cash and cash equivalents94,38695,817157,46389,042133,256104,261
Short-term investments 2,50127,48069,97224,00020,500
Receivables29,84324,10223,07920,77523,82527,598
Inventory, net of allowances, customer advances and progress billings36,01046,20921,99521,30022,03515,983
Inventory36,01046,20921,99521,30022,03515,983
Other undisclosed current assets8,2898,7544,2891,8543,2112,098
Total current assets:168,528177,383234,306202,943206,327170,440
Noncurrent Assets
Operating lease, right-of-use asset20,95722,61922,864
Property, plant and equipment47,60250,61350,78354,11156,18352,296
Intangible assets, net (including goodwill)90,16399,57015,27917,04218,85317,441
Goodwill7,7818,4137,6947,8518,2187,214
Intangible assets, net (excluding goodwill)82,38291,1577,5859,19110,63510,227
Other noncurrent assets20,28515,4207,4784,8971,254 
Other undisclosed noncurrent assets     69
Total noncurrent assets:179,007188,22296,40476,05076,29069,806
TOTAL ASSETS:347,535365,605330,710278,993282,617240,246
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,80520,76313,95510,19613,0738,799
Accounts payable7,6338,9843,8323,1436,7472,303
Accrued liabilities4,6494,4344,2932,2226,3266,496
Employee-related liabilities9,5237,3455,8304,446  
Taxes payable   385  
Debt 148    
Business combination, contingent consideration, liability4,31513,090    
Other undisclosed current liabilities3,6752,8662,3221,093  
Total current liabilities:29,79536,86716,27711,28913,0738,799
Noncurrent Liabilities
Long-term debt and lease obligation19,24020,87921,367   
Operating lease, liability19,24020,87921,367
Liabilities, other than long-term debt11,41535,4594,6884,0926,0538,674
Deferred revenue and credits 48
Deferred tax liabilities, net3,5425,3936,548
Deferred income tax liabilities10,15711,8954,331
Other liabilities1,2581,2443575506602,078
Business combination, contingent consideration, liability 22,320    
Total noncurrent liabilities:30,65556,33826,0554,0926,0538,674
Total liabilities:60,45093,20542,33215,38119,12617,473
Stockholders' equity
Stockholders' equity attributable to parent287,085272,400288,378263,612263,491222,773
Common stock144143143142147146
Additional paid in capital67,08155,35548,70750,76368,61761,735
Accumulated other comprehensive loss(5,718)(4,542)(5,898)(5,526)(4,784)(7,317)
Retained earnings225,578221,444245,426218,233199,511168,209
Total stockholders' equity:287,085272,400288,378263,612263,491222,773
TOTAL LIABILITIES AND EQUITY:347,535365,605330,710278,993282,617240,246

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues147,794130,457114,610105,555113,420103,379
Revenue, net113,420103,379
Cost of revenue
(Cost of Goods and Services Sold)
(64,851)(61,431)(28,747)(31,280)(27,364)(24,027)
Gross profit:82,94369,02685,86374,27586,05679,352
Operating expenses(101,423)(126,014)(51,615)(52,526)(40,327)(28,745)
Other undisclosed operating income21,09528,666    
Operating income (loss):2,615(28,322)34,24821,74945,72950,607
Interest and debt expense(19)(25)    
Income (loss) from continuing operations before equity method investments, income taxes:2,596(28,347)34,24821,74945,72950,607
Other undisclosed income (loss) from continuing operations before income taxes(169)(277)1,8731,458473263
Income (loss) from continuing operations before income taxes:2,427(28,624)36,12123,20746,20250,870
Income tax expense (benefit)1,7074,642(8,928)(4,485)(14,386)(18,323)
Net income (loss) available to common stockholders, diluted:4,134(23,982)27,19318,72231,81632,547

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):4,134(23,982)27,19318,72231,81632,547
Other comprehensive income (loss)(1,176)1,356(372)(742)2,533(668)
Comprehensive income (loss), net of tax, attributable to parent:2,958(22,626)26,82117,98034,34931,879

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: